Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy (ARIES)
This study has been terminated.
(No results are avaialble as the study did not complete according to the protocol)
Information provided by (Responsible Party):
First received: October 9, 2007
Last updated: February 6, 2013
Last verified: February 2013
The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by AstraZeneca:
Contacts and Locations